LUNA PHARMA CONSULTING LTDActive

Company number 10241868Private limited companyIncorporated 2016

Key figures

£606,833-35.5%
Net assets 2025/26
-2.0%
Average annual change 2019/20–2025/26
0500 k1 m1.5 m2 m2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, LUNA PHARMA CONSULTING LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand1,737,5791,432,7491,237,276945,651585,770
Total assets1,745,2031,440,5451,274,468968,099626,023
Total liabilities133,1137,38613,41228,15221,665
Net assets / total equity1,613,6911,434,2471,262,312941,243606,833
Average number of employees22223

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: LUNA PHARMA CONSULTING LTD

Company

LUNA PHARMA CONSULTING LTD is a private limited company registered with Companies House under company number 10241868. It was incorporated on 21 Jun 2016. Its status is active. The registered office is in Tonbridge (TN12). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 May 2026); the company files small company accounts (filleted). Net assets were £606,833, down 35.5% on the previous year. Cash at bank and in hand was £585,770. Total assets were £626,023 and total liabilities £21,665. The company had an average of 3 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

The company has 1 current director. One person with significant control is registered.

Filing deadlines

The next accounts are due by 29 Feb 2028. The next confirmation statement is due by 4 Jul 2027.